Ensuring timely antibody delivery in the face of supply chain challenges - contact us for solutions

Hamster Anti-Mouse CD28-SPRD (37.51)

Cat. No.:
1610-13
PE/CY5 (SPRD) Anti-Mouse CD28 antibody for use in flow cytometry assays.
$270.00
Size Price (USD) Quantity
0.1 mg $270.00
More Information
Clone 37.51
Isotype Hamster (Syrian) IgG2
Isotype Control Hamster IgG-SPRD
Specificity Mouse CD28
Alternative Names Tp44, T44
Description CD28 is a type I disulfide-linked homodimer that is constitutively expressed on most thymocytes, at low density on nearly all CD4+ and CD8+ peripheral T lymphocytes and at very low levels on NK cells. Its expression is upregulated upon T-cell activation. CD28 is a ligand for CD80 (B7-1) and CD86 (B7-2) on B cells and other antigen presenting cells and plays an important role in the interaction between T cells and B cells. CD28 is a costimulatory receptor involved in many, but not all, T-cell independent immune responses.
Immunogen C57BL/6N mouse T cell lymphoma EL-4 cell line
Conjugate SPRD (R-phycoerythrin/Cyanine 5)
Buffer Formulation Phosphate buffered saline containing < 0.1% sodium azide and a stabilizer
Clonality Monoclonal
Concentration 0.1 mg/mL
Volume 1.0 mL
Recommended Storage 2-8°C; Avoid exposure to light; Do not freeze
Trademark Information Spectral Red® is a registered trademark of Southern Biotechnology Associates, Inc.
Spectral Red® is a PE/CY5 tandem conjugate
Cy® is a registered trademark of Global Life Sciences Solutions Germany GmbH
Applications Flow Cytometry – Quality tested 1,2
Immunoprecipitation – Reported in literature 1
Costimulation – Reported in literature 1-3,7-9,11
Stimulation – Reported in literature 10
Activation – Reported in literature 5
Blocking – Reported in literature 6

RRID Number AB_2795027
Gene ID 12487 (Mouse)
Gene ID Symbol Cd28 (Mouse)
UniProt ID P31041 (Mouse)
UniProt Name CD28_MOUSE (Mouse)

Certificate of Analysis Lookup

Enter the Catalog Number and Lot Number for the Certificate of Analysis you wish to view


Need help with this product?
or call 800.722.2255
  1. 1. Gross JA, Callas E, Allison JP. Identification and distribution of the costimulatory receptor CD28 in mouse. J Immunol. 1992;149:380-8. (Immunogen, FC, IP, Costim)
  2. 2. Silverio JC, Pereira IR, Cipitelli M, Vinagre NF, Rodrigues MM, Gazzinelli RT, et al. CD8+ T-cells expressing interferon gamma or perforin play antagonistic roles in heart injury in experimental Trypanosoma cruzi-elicited cardiomyopathy. PLoS Pathog. 2012;8(4):e1002645. (Costim)
  3. 3. Lin J, Harding A, Giurisato E, Shaw AS. KSR1 modulates the sensitivity of mitogen-activated protein kinase pathway activation in T cells without altering fundamental system outputs. Mol Cell Biol. 2009;29:2082-91. (Costim)
  4. 4. Nandi D, Gross JA, Allison JP. CD28-mediated costimulation is necessary for optimal proliferation of murine NK cells. J immunol. 1994;152:3361-9. (FC, Costim)
  5. 5. Cibotti R, Punt JA, Dash KS, Sharrow SO, Singer A. Surface molecules that drive T cell development in vitro in the absence of thymic epithelium and in the absence of lineage-specific signals. Immunity. 1997;6:245-55. (Activ)
  6. 6. Nishio M, Spielman J, Lee RK, Nelson DL, Podack ER. CD80 (B7.1) and CD54 (intracellular adhesion molecule-1) induce target cell susceptibility to promiscuous cytotoxic T cell lysis. J Immunol. 1996;157:4347-53. (Block)
  7. 7. Kim EH, Sullivan JA, Plisch EH, Tejera MM, Jatzek A, Choi KY, et al. Signal integration by Akt regulates CD8 T cell effector and memory differentiation. J Immunol. 2012;188:4305-14. (Costim)
  8. 8. Yoshida K, Sakamoto A, Yamashita K, Arguni E, Horigome S, Arima M, et al. Bcl6 controls granzyme B expression in effector CD8+ T cells. Eur J Immunol. 2006;36:3146-56. (Costim)
  9. 9. Belhacéne N, Gamas P, Gonçalvès D, Jacquin M, Beneteau M, Jacquel A, et al. Severe thymic atrophy in a mouse model of skin inflammation accounts for impaired TNFR1 signaling. PLoS One. 2012;7(10):e47321. (Costim)
  10. 10. Zhang T, Fresnay S, Welty E, Sangrampurkar N, Rybak E, Zhou H, et al. Selective CD28 blockade attenuates acute and chronic rejection of murine cardiac allografts in a CTLA-4-dependent manner. Am J Transplant. 2011;11:1599-1609. (Stim)
  11. 11. Shen XZ, Okwan-Doudu D, Blackwell W, Ong FS, Janjulia T, Bernstein EA. Myeloid expression of angiotensin-converting enzyme facilitates myeloid maturation and inhibits the development of myeloid-derived suppressor cells. Lab Invest. 2014;94:536-44. (Costim)
See All References